Dyne Therapeutics, Inc. DYN Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Returns | |||||
| Return on equity | -55.7%+32.3pp | -88%+49.3pp | -137.3%-83.1pp | -54.2%-12.2pp | |
| Return on invested capital | -200.8%— | —— | —— | -110%+13.8pp | |
| Liquidity | |||||
| Current ratio | 22.3×+6.7× | 15.6×+13.1× | 2.5×-6.9× | 9.5×-3.9× | |
| Leverage | |||||
| Debt-to-equity | 0.2×+0.1× | 0×-0.3× | 0.3×+0.2× | 0.1×0.0× | |
| Valuation | |||||
| Market capitalization | $3.22B+34.3% | $2.4B+194% | $816.53M+34.3% | $608.11M-0.9% | |
| Price / book | 3.3×-0.5× | 3.8×-5.1× | 8.9×+6.5× | 2.4×+0.7× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Dyne Therapeutics, Inc.'s ratios come from?
- Every ratio is computed from Dyne Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.